San DiegoBiotechnologyHealthcareHealth CareBiotechnology Research
Description
Daré Bioscience, Inc. announced a definitive securities purchase agreement with institutional investors for a registered direct offering of $6.0 million. The offering involves the sale of over 4.3 million shares at $1.37 each. Concurrently, the company will issue Series A and Series B warrants to purchase more shares
Who to call at Daré Bioscience, Inc., and when
A new round usually means Daré Bioscience, Inc. is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Daré Bioscience, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Daré Bioscience, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Daré Bioscience, Inc.. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Daré Bioscience, Inc.
Location
3655 Nobel Drive
San Diego, California, United States
About
Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Daré Bioscience, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoBiotechnologyHealthcareHealth CareBiotechnology Research